Welcome to the 
Delaware Society for Clinical Oncology

Molecular Biomarkers in Cancer

  • 16 May 2013
  • 6:30 PM
  • Sullivan's Steakhouse

Molecular Biomarkers in Cancer will be presented by Scott Dessain, MD, Lankenau Institute for Medical Research, Wynnewood, PA.


MBoC is an educational initiative sponsored by Genentech BioOncology to provide a synopsis of fundamental and evolving concepts on key molecular biomarkers currently impacting the diagnosis and treatment of cancer.


This presentation includes:


-A historical perspective on prognostic and predictive biomarkers in cancer

-A review of biomarkers currently used in screening, diagnosis, disease monitoring, and drugresponse/resistance

-Details on advanced molecular techniques helpful in the detection and analysis of biomarkers

-Discussion of major challenges faced during conception, validation, and use of cancer biomarkers

-Tumor type profiling exercises that review the detection and use of biomarkers in clinical practice  


Register online at www.genersvp.com.


Please note that this a non-promotional, industry sponsored event and is NOT accredited for CME.


Delaware Society for Clinical Oncology
c/o Megan Hayes
Medical Society of Delaware
PO Box 8155, Newark, Delaware 19714
Tel: 302-224-5181, Fax: 302-366-1354, Email: Megan.Hayes@medsocdel.org

This website brought to you by:


Terms and Conditions of Use

 Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds

Powered by Wild Apricot Membership Software